VistaGen Therapeutics Inc. to Present at TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
Reuters
Sep 09
VistaGen <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Inc. to Present at TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy <a href="https://laohu8.com/S/SMMT">Summit</a>
VistaGen Therapeutics Inc., a late clinical-stage biopharmaceutical company, will participate in the TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit. The event is scheduled for Thursday, September 18. President and CEO Shawn Singh will engage in a fireside chat, which will be accessible via a live webcast on Vistagen's website, with a replay available after the presentation.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250909384975) on September 09, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.